Recycled pacemakers can function as well as new devices, a University of Michigan-led study suggests. These used and reconditioned devices have the potential to increase access to pacemaker therapy in ...
A new, tiny pacemaker — smaller than a grain of rice — developed at Northwestern University near Chicago could play a sizeable role in the future of medicine, according to the engineers who developed ...
MUSKEGON, Mich. — Trinity Health Muskegon was the first in the region to implant a new innovative pacemaker. The AVEIR DR, made by Abbott, is the world's first dual-chamber leadless pacemaker. "It's ...
Roughly one percent of infants are born with heart defects every year. The majority of these cases only require a temporary implant for about seven days to allow time for the heart to naturally ...
Please provide your email address to receive an email when new articles are posted on . The My Heart Your Heart study compared reconditioned pacemakers with that of new pacemakers among patients in ...
CHICAGO — One person’s used pacemaker is another person’s treasure. A program to refurbish used pacemakers could expand access to the lifesaving devices. In a clinical trial of nearly 300 people, ...
CHICAGO, IL—Reconditioned pacemakers carry the same low infection rate as new devices out to 90 days, according to preliminary data from the international My Heart Your Heart trial. The findings ...
Reconditioned pacemakers are as safe as new ones, and work just as well, preliminary results from the My Heart Your Heart trial show, which could help more people receive lifesaving devices. More than ...
Jerry Karzen has had many successes as both a tennis player and a coach. Now he is getting the chance to extend those accomplishments with the assistance of a new generation of pacemaker. In January, ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- ...
The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results